AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2032104 — intervention group
Group type: EXPERIMENTAL
Intervention: Anal endosonography
Number of subjects: 13
Study 2032104 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyography
Number of subjects: 13
Study 7034161 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular testosterone (Triolandren, 348 mg)
Number of subjects: 24
Study 7034161 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone propionate injections (84 mg every other day)
Number of subjects: 24
Study 7034161 — intervention group
Group type: EXPERIMENTAL
Intervention: Peroral testosterone administration (800 mg micronized free testosterone daily)
Number of subjects: 24
Study 31909912 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended training (2 hours of virtual training and 2 hours of in-person instruction)
Number of subjects: 89
Study 31909912 — intervention group
Group type: COMPARATOR
Intervention: Standard training (4 hours of standard instruction from a trainer)
Number of subjects: 89
Study 31909912 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Blended and Standard)
Number of subjects: 89
Study 31909912 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended training and Standard training
Number of subjects: 89
Study 31455936 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye health education via various methods (radio, television)
Number of subjects: 15000
Study 31455936 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio for health education in Doti
Number of subjects: 15000
Study 31455936 — intervention group
Group type: EXPERIMENTAL
Intervention: Television for health education in Saptari
Number of subjects: 15000
Study 31455936 — intervention group
Group type: EXPERIMENTAL
Intervention: Dependence on drug retailers, self-medication, and traditional healers
Number of subjects: 15000
Study 28315891 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice/lentil RUCF
Number of subjects: 5000
Study 28315891 — intervention group
Group type: EXPERIMENTAL
Intervention: Chickpea RUCF
Number of subjects: 5000
Study 28315891 — intervention group
Group type: EXPERIMENTAL
Intervention: Plumpy'doz
Number of subjects: 5000
Study 28315891 — intervention group
Group type: COMPARATOR
Intervention: WSB++
Number of subjects: 5000
Study 25912336 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-PCMSsingle
Number of subjects: 10
Study 25912336 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-PCMSspaced
Number of subjects: 10
Study 25912336 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-PCMS
Number of subjects: 10
Study 25912336 — intervention group
Group type: COMPARATOR
Intervention: 50-TMS
Number of subjects: 10
Study 25912336 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall MEPs
Number of subjects: 10
Study 24487701 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (rTMS) over supplementary motor area
Number of subjects: 19
Study 24487701 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 19
Study 24487701 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 19
Study 22776019 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone plus placebo (n = 210)
Number of subjects: 829
Study 22776019 — intervention group
Group type: EXPERIMENTAL
Intervention: Valaciclovir plus placebo (n = 207)
Number of subjects: 829
Study 22776019 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone plus valaciclovir (n = 206)
Number of subjects: 829
Study 22776019 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus placebo (n = 206)
Number of subjects: 829
Study 19487942 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program focusing on hand hygiene and catheter care
Number of subjects: 999
Study 17520791 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation (NPPV)
Number of subjects: 21
Study 17520791 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive servoventilation (ASV)
Number of subjects: 21
Study 15126538 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin and resistance training three times a week
Number of subjects: 25
Study 15126538 — intervention group
Group type: COMPARATOR
Intervention: Metformin alone
Number of subjects: 25
Study 11590477 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance groups (R, TA, CJ, CP)
Number of subjects: 94
Study 11590477 — intervention group
Group type: EXPERIMENTAL
Intervention: DHS
Number of subjects: 94
Study 11590477 — intervention group
Group type: EXPERIMENTAL
Intervention: S
Number of subjects: 94
Study 11590477 — intervention group
Group type: EXPERIMENTAL
Intervention: All endurance disciplines
Number of subjects: 94
Study 11590477 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole group
Number of subjects: 94
Study 11590477 — intervention group
Group type: COMPARATOR
Intervention: UT
Number of subjects: 94
Study 11590477 — intervention group
Group type: COMPARATOR
Intervention: LS
Number of subjects: 94
Study 9855386 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet alone
Number of subjects: 45
Study 9855386 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and aerobic training
Number of subjects: 45
Study 9855386 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and strength training
Number of subjects: 45
Study 9855386 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 45
Study 7857455 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal movement counting
Number of subjects: 613
Study 7857455 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep recording
Number of subjects: 613
Study 7857455 — intervention group
Group type: COMPARATOR
Intervention: Nonrecording control group
Number of subjects: 613
Study 2792461 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 alpha‐OHD group (0.75 micrograms of 1 alpha‐OHD and 400 mg of calcium daily)
Number of subjects: 38
Study 2792461 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazide group (1 alpha‐OHD, calcium and 4 mg of trichlormethiazide)
Number of subjects: 38
Study 2792461 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment for osteoporosis)
Number of subjects: 38
Study 800385 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% diflorasone diacetate cream
Number of subjects: 384
Study 800385 — intervention group
Group type: COMPARATOR
Intervention: 0.05% fluocinonide cream
Number of subjects: 384
Study 30047785 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth behaviour change intervention
Number of subjects: 310
Study 30047785 — intervention group
Group type: EXPERIMENTAL
Intervention: self-allocated stage outcomes
Number of subjects: 310
Study 30047785 — intervention group
Group type: EXPERIMENTAL
Intervention: social-cognitive variables
Number of subjects: 310
Study 30047785 — intervention group
Group type: EXPERIMENTAL
Intervention: stage measures validity
Number of subjects: 310
Study 28916537 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 0
Study 25575977 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SRS)
Number of subjects: 35
Study 25575977 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy (SRT)
Number of subjects: 35
Study 25575977 — intervention group
Group type: EXPERIMENTAL
Intervention: SRS/SRT
Number of subjects: 35
Study 22926233 — intervention group
Group type: EXPERIMENTAL
Intervention: Zileuton ER 2400 mg/d
Number of subjects: 210
Study 22926233 — intervention group
Group type: COMPARATOR
Intervention: Montelukast 10 mg/d
Number of subjects: 210
Study 20974066 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptability E-scale
Number of subjects: 627
Study 19522258 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (M group, n=29)
Number of subjects: 58
Study 19522258 — intervention group
Group type: COMPARATOR
Intervention: Control (C group, n=29)
Number of subjects: 58
Study 17466593 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified Training (IT)
Number of subjects: 16
Study 17466593 — intervention group
Group type: COMPARATOR
Intervention: Normal Training (NT)
Number of subjects: 16
Study 15191153 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine intradermal injection
Number of subjects: 68
Study 15191153 — intervention group
Group type: COMPARATOR
Intervention: Saline intradermal injection (Control)
Number of subjects: 68
Study 11703413 — intervention group
Group type: EXPERIMENTAL
Intervention: PA‐IgG against GP V (ratio > or = 1.5)
Number of subjects: 69
Study 11703413 — intervention group
Group type: EXPERIMENTAL
Intervention: Degree of PA‐IgG measured by PIFT
Number of subjects: 69
Study 11703413 — intervention group
Group type: EXPERIMENTAL
Intervention: GP V‐specific antibodies
Number of subjects: 69
Study 11703413 — intervention group
Group type: EXPERIMENTAL
Intervention: GP V‐specific PA‐IgG
Number of subjects: 69
Study 9497188 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin
Number of subjects: 12
Study 9497188 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructooligosaccharide
Number of subjects: 12
Study 9497188 — intervention group
Group type: EXPERIMENTAL
Intervention: Galactooligosaccharide
Number of subjects: 12
Study 9497188 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 12
Study 7868978 — intervention group
Group type: COMPARATOR
Intervention: Dietary cholesterol 0 mg (no fat, no cholesterol)
Number of subjects: 10
Study 7868978 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cholesterol 140 mg
Number of subjects: 10
Study 7868978 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cholesterol 280 mg
Number of subjects: 10
Study 7868978 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cholesterol 710 mg
Number of subjects: 10
Study 3283987 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention
Number of subjects: 114
Study 3283987 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 114
Study 3283987 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 114
Study 3283987 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 114
Study 29306945 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly semistandardized e‐mail feedback from psychologists (individual counseling)
Number of subjects: 1089
Study 29306945 — intervention group
Group type: COMPARATOR
Intervention: Automated, standardized feedback where a psychologist could be contacted on demand (CoD)
Number of subjects: 1089
Study 27874934 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation combined with inhalational NO therapy
Number of subjects: 86
Study 27874934 — intervention group
Group type: COMPARATOR
Intervention: High-frequency oscillatory ventilation
Number of subjects: 86
Study 24700467 — intervention group
Group type: COMPARATOR
Intervention: Continuous wave CO2 laser (5 W)
Number of subjects: 100
Study 24700467 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed CO2 laser (140 Hz, 400 microseconds, 33 mJ, 4.62 W)
Number of subjects: 100
Study 22458660 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferential current (n = 21)
Number of subjects: 41
Study 22458660 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 41
Study 20004661 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg farglitazar
Number of subjects: 265
Study 20004661 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg farglitazar
Number of subjects: 265
Study 20004661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study 18407452 — intervention group
Group type: EXPERIMENTAL
Intervention: ACUSEAL (Gore-Tex) patching
Number of subjects: 200
Study 18407452 — intervention group
Group type: COMPARATOR
Intervention: Finesse (Hemashield) patching
Number of subjects: 200
Study 16159938 — intervention group
Group type: EXPERIMENTAL
Intervention: Cosyntropin 1.0 microg/kg
Number of subjects: 276
Study 16159938 — intervention group
Group type: COMPARATOR
Intervention: Cosyntropin 0.1 microg/kg
Number of subjects: 276
Study 12677095 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-free hydrophilic microemulsion (ME)
Number of subjects: 20
Study 12677095 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-free lipophilic microemulsion (ME)
Number of subjects: 20
Study 12677095 — intervention group
Group type: COMPARATOR
Intervention: 5% salicylic acid gel
Number of subjects: 20
Study 12677095 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 20
Study 14728001 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glycoprotein IIb/IIIa inhibitors
Number of subjects: 42000
Study 9034269 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone
Number of subjects: 6
Study 9034269 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 6
Study 9034269 — intervention group
Group type: COMPARATOR
Intervention: IL-1beta (control)
Number of subjects: 6
Study 9034269 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophil pretreatment with inotropes
Number of subjects: 6
Study 8290675 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment
Number of subjects: 90
Study 8290675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 3554943 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 23
Study 3554943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 29706170 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 228
Study 29706170 — intervention group
Group type: COMPARATOR
Intervention: Alcohol Education (AE)
Number of subjects: 228
Study 27121724 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐2‐1‐0 intervention program
Number of subjects: 8
Study 27121724 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 8
Study 25695061 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (8 mg before induction of anesthesia)
Number of subjects: 120
Study 25695061 — intervention group
Group type: COMPARATOR
Intervention: Subhypnotic propofol (1 mg/kg/h during operation)
Number of subjects: 120
Study 25695061 — intervention group
Group type: COMPARATOR
Intervention: Control group (10% intralipid infusion)
Number of subjects: 120
Study 23879477 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser enucleation of the prostate (DiLEP)
Number of subjects: 80
Study 23879477 — intervention group
Group type: COMPARATOR
Intervention: Plasmakinetic enucleation and resection of the prostate (PKERP)
Number of subjects: 80
Study 20621711 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (400 mg/day)
Number of subjects: 120
Study 20621711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 20621711 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 120
Study 17692949 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation during surgery
Number of subjects: 52
Study 17692949 — intervention group
Group type: COMPARATOR
Intervention: Control group (no magnesium supplementation)
Number of subjects: 52
Study 16803840 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) ablation
Number of subjects: 71
Study 16803840 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation (CA)
Number of subjects: 71
Study 14709929 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 11056241 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT) as a daily oral dose of estradiol, 2 mg, and norethisterone acetate, 1 mg, plus monthly subcutaneous implants of goserelin acetate for up to 2 years.
Number of subjects: 49
Study 11056241 — intervention group
Group type: COMPARATOR
Intervention: Monthly subcutaneous implants of goserelin acetate for up to 2 years without HRT.
Number of subjects: 49
Study 8822684 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine patch delivering 0.2mg/d
Number of subjects: 0
Study 8822684 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31240553 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary care (physician, pharmacist, and nurse)
Number of subjects: 143
Study 31240553 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 143
Study 30137193 — intervention group
Group type: EXPERIMENTAL
Intervention: Lefitolimod maintenance therapy
Number of subjects: 103
Study 30137193 — intervention group
Group type: COMPARATOR
Intervention: Local standard of care
Number of subjects: 103
Study 27437913 — intervention group
Group type: EXPERIMENTAL
Intervention: L-thyroxine for 3-6 months
Number of subjects: 32
Study 27437913 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal thyroid function)
Number of subjects: 32
Study 25323094 — intervention group
Group type: EXPERIMENTAL
Intervention: CSCCM Instructional Module (2-h didactic session, 8-h preclinical session, 8-h clinical session, 1-h Q&A)
Number of subjects: 26
Study 25323094 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 26
Study 22375570 — intervention group
Group type: EXPERIMENTAL
Intervention: PATHS program (90‐minute, small‐group, participatory workshop with 6 months of structured telephone support)
Number of subjects: 211
Study 22375570 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 211
Study 18275866 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection duration of 25 s
Number of subjects: 75
Study 18275866 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection duration of 30 s
Number of subjects: 75
Study 18275866 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection duration of 35 s
Number of subjects: 75
Study 18275866 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection duration of 40 s
Number of subjects: 75
Study 18275866 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection duration of 45 s
Number of subjects: 75
Study 16574922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 16574922 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 microg/kg desmoteplase
Number of subjects: 37
Study 16574922 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 microg/kg desmoteplase
Number of subjects: 37
Study 14560188 — intervention group
Group type: EXPERIMENTAL
Intervention: Disc Replacement
Number of subjects: 53
Study 14560188 — intervention group
Group type: COMPARATOR
Intervention: Fusion
Number of subjects: 53
Study 10671887 — intervention group
Group type: EXPERIMENTAL
Intervention: Left spermatic vein ligation
Number of subjects: 68
Study 10671887 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 68
Study 9107169 — intervention group
Group type: EXPERIMENTAL
Intervention: CPI waveform with 60% positive‐phase (P1) tilt and 50% negative‐phase (P2) tilt
Number of subjects: 42
Study 9107169 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic waveform with 65% fixed tilt in both P1 and P2
Number of subjects: 42
Study 9107169 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventritex waveform with 60% P1 tilt and a P2 leading edge voltage equal to half of the P1 trailing edge voltage
Number of subjects: 42
Study 9107169 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic waveforms with equal P1 tilt at 65% but shorter P2 duration or smaller P2 peak voltage
Number of subjects: 42
Study 7513512 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranilast 300 mg daily for 6 to 7 weeks before the onset of the pollen season and continuously during the season
Number of subjects: 38
Study 7513512 — intervention group
Group type: COMPARATOR
Intervention: No medication including tranilast until the onset of clinical symptoms in season
Number of subjects: 38
Study 3743153 — intervention group
Group type: EXPERIMENTAL
Intervention: albuterol administered by metered‐dose inhaler
Number of subjects: 19
Study 3743153 — intervention group
Group type: COMPARATOR
Intervention: albuterol administered by ultrasonic nebulizer
Number of subjects: 19
Study 3743153 — intervention group
Group type: COMPARATOR
Intervention: Freon (placebo effect from metered‐dose inhaler)
Number of subjects: 19
Study 3743153 — intervention group
Group type: COMPARATOR
Intervention: isotonic saline solution (placebo effect from ultrasonic nebulizer)
Number of subjects: 19
Study 30343620 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabrafenib plus trametinib
Number of subjects: 0
Study 30343620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27886073 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet intervention (300-500 kcal/day less energy intake, optimized nutrient composition, three face-to-face counseling sessions, online supervision 1-3 times per week)
Number of subjects: 49
Study 27886073 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet intervention
Number of subjects: 49
Study 27886073 — intervention group
Group type: COMPARATOR
Intervention: Control (maintain habitual lifestyle)
Number of subjects: 49
Study 24962185 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboxymethylcellulose sodium hyaluronate adhesion barrier (CMHAB)
Number of subjects: 30
Study 24962185 — intervention group
Group type: COMPARATOR
Intervention: No adhesion barrier (NAB)
Number of subjects: 30
Study 22652985 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard rehabilitation plus NMES applied 2 times per day at maximal tolerable intensity for 15 contractions for 6 weeks after TKA.
Number of subjects: 30
Study 22652985 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard rehabilitation plus NMES
Number of subjects: 30
Study 22652985 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation
Number of subjects: 30
Study 20137069 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher PICOT score
Number of subjects: 89
Study 20137069 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured research question
Number of subjects: 89
Study 18672629 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9 mg of atropine plus 2.5 mg of neostigmine
Number of subjects: 46
Study 18672629 — intervention group
Group type: COMPARATOR
Intervention: 1.2 mg of atropine plus 2.5 mg of neostigmine
Number of subjects: 46
Study 16528650 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid fatty meal
Number of subjects: 84
Study 16528650 — intervention group
Group type: COMPARATOR
Intervention: Non-fat meal
Number of subjects: 84